Skip to main content
. 2021 Oct 12;13(20):5117. doi: 10.3390/cancers13205117

Table 6.

Molecular profiling studies revealing p53 pathway alterations in pNETs.

Technique Reference Key Findings
Sequencing and mutational analysis [11] Inactivating TP53 mutations found in 4 of 7 pNECs, however, in none of 11 well-differentiated pNETs.
[24] TP53 gene mutations identified in 3% of 68 pNETs.
PCR and IHC [157] Amplification of the MDM2 gene in 22% (38 of 169), MDM4 in 30% (45 of 150), and WIP1 in 76% (34 of 45) well differential pNETs, which correlated with corresponding changes in mRNA and protein expression.
IHC [11] 11 well differentiated pNETs exhibited normal p53 labeling, however, abnormal labeling observed in 9 (100%) small cell pNECs and 9 of 10 (90%) large cell pNECs.